"Exploring the Potential of Vaccines and Monoclonal Antibodies in Combating Addiction and Overdoses"
Researchers are intensifying efforts to develop vaccines and antibody therapies to combat the opioid crisis in the United States. With millions of dollars in federal funding, scientists are working on monoclonal antibodies that could target substances like fentanyl, the deadliest street drug in the country. These antibodies would bind to the drug molecules, preventing them from reaching the brain and causing overdose. Clinical trials are also underway for vaccines targeting opioids like oxycodone, heroin, and methamphetamine. However, skeptics argue that existing medications and overdose reversal drugs should be prioritized over expensive antibody treatments, and there are concerns about the cost and feasibility of frequent treatments for drug users.
